Israel Corporation reported $1.85B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Avient USD 761M 46M Dec/2025
Chemours USD 1.3B 200M Dec/2025
Corteva USD 3.91B 1.29B Dec/2025
ICL Group USD 1.7B 150M Dec/2025
Israel Corporation USD 1.85B 21M Sep/2025
PhosAgro RUB 143.18B 4.01B Sep/2025
UPL INR 123.61B 3.42B Dec/2025